High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$49K
$49,524
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VIR
S
Vir Biotechnology, Inc.
Eisner Mark
• Officer • EVP and Chief Medical Officer
10b5-1 Sell
2026-02-25
$18,550
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • EVP and Chief Medical Officer
10b5-1 Sell
|
2026-02-25 | $18,550 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
Eisner Mark
• Officer • EVP and Chief Medical Officer
Sell to Cover
2026-02-24
$15,405
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • EVP and Chief Medical Officer
Sell to Cover
|
2026-02-24 | $15,405 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
Eisner Mark
• Officer • EVP and Chief Medical Officer
Sell to Cover
2026-02-23
$15,569
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • EVP and Chief Medical Officer
Sell to Cover
|
2026-02-23 | $15,569 | S | Form 4 |